September 22-23, 2003Bethesda, Maryland
As part of its contribution to influenza pandemic preparedness and response, the National Institute of Allergy and Infectious Diseases sponsored a workshop “Development of a Clinical Trial Plan for Pandemic Influenza Vaccines” on September 22-23, 2003 in Bethesda, Maryland. Participants attending this workshop included individuals from HHS, FDA, CDC, USDA, and WHO and representatives from Industry.
The goal of this meeting was to frame a research plan for the development and clinical evaluation of pandemic influenza vaccines. The primary objectives of this workshop were to
Meeting Agenda (PDF)
Meeting Participants (PDF)
Meeting Summary (PDF)
Last Updated October 13, 2008